HIV 1 News and Research

RSS

Bill introduced in U.S. Senate is latest push to award prizes for new drug development

"As Washington prepares for a major international AIDS conference this summer, developments on the drug front are once again elevating the subject of the continuing epidemic in the public eye," CQ HealthBeat reports.

22 May 2012

Government-supported 'Prize Funds' would help important drugs have greater social impact

"Every year, millions of people die from preventable and treatable diseases, especially in poor countries," World Bank Chief Economist Joseph Stiglitz, a Nobel laureate, writes in this BusinessDay opinion piece.

22 May 2012

First Edition: May 21, 2012

Today's headlines includes reports on a new poll that explores what it is like to be sick in America.

21 May 2012

Modeling data shows vaccine can build on HIV/AIDS prevention tools

In this post in USAID's "IMPACTblog," International AIDS Vaccine Initiative (IAVI) President and CEO Margaret McGlynn discusses new modeling data from IAVI and the Futures Institute, with support from USAID, which "illustrates how a safe, preventive HIV vaccine that is accessible and affordable can help us end the AIDS pandemic."

19 May 2012

Viewpoints: VA failing to provide timely care; Roll up your sleeves to help fight AIDS; Primary care doctors' uncertain future

Those who have served know the military rules: Be on time, do it now. Once they file disability claims with the Department of Veteran Affairs, however, veterans wait, and wait longer…. Delay is not without consequences for the individual or the community…. We sent these young men and women off to battle. We owe them timely care.

19 May 2012

IAS’ XIX International AIDS Conference to take place in Washington D.C.

This summer, more than 25,000 leading scientists, public health experts, policy-makers, community members, and experts in the HIV/AIDS field from around the world will gather in our nation's capital for the International AIDS Society's XIX International AIDS Conference.

19 May 2012

Promising updates in quest for early detection and treatments for lung cancer

LUNGevity Foundation, the nation's largest lung cancer-focused nonprofit, is pleased to note promising updates in researchers' quest for early detection and treatments for lung cancer during May, Lung Cancer Hope Month.

18 May 2012

Ugandan AIDS activists concerned over proposed cuts in nation's health budget

AIDS activists in Uganda are worried about a proposed reduction in the country's health budget, as Parliament begins "a months-long budgeting process for the ... next fiscal year," VOA News reports.

18 May 2012

House Appropriations Committee releases draft report on FY13 State, Foreign Operations spending bill

The House Appropriations Committee is scheduled to mark up the FY 2013 State and Foreign Operations appropriations bill on Thursday, The Hill's "Global Affairs" blog reports.

18 May 2012

More research needed into how transgender persons in Asia, Pacific affected by HIV, stigma, report says

A report released Thursday in Bangkok by the United Nations Development Programme (UNDP) and the Asia Pacific Transgender Network (APTN) says more research needs to be conducted to determine the extent to which transgender persons in Asia and the Pacific are affected by HIV, are socially ostracized, and lack fundamental rights, including access to basic health care, a UNDP press release reports.

18 May 2012

Tiny filter could fight against tuberculosis

A tiny filter could have a big impact around the world in the fight against tuberculosis. Using the traditional microscope-based diagnosis method as a starting point, a University of Florida lung disease specialist and colleagues in Brazil have devised a way to detect more cases of the bacterial infection.

18 May 2012

Inovio SynCon avian influenza vaccine demonstrates broad coverage

Inovio Pharmaceuticals, Inc. announced today that its SynCon avian influenza vaccine generated protective HAI titers against six different unmatched strains of H5N1 in a phase I clinical trial - a distinct clinical achievement on Inovio's path to develop universal influenza vaccines.

17 May 2012

Mary Ann Liebert releases BioResearch Open Access journal

The inaugural issue of BioResearch Open Access, a new bimonthly peer-reviewed open access journal, was released today by Mary Ann Liebert, Inc., publishers. The Journal provides a new rapid-publication forum for a broad range of scientific topics including but not limited to molecular and cellular biology, tissue engineering and biomaterials, regenerative medicine, stem cells, gene therapy, systems biology, genetics, biochemistry, virology, microbiology, and neuroscience.

17 May 2012

MDG Health Alliance introduced at GBCHealth Conference

The MDG Health Alliance, an innovative new private sector organization created and led by eminent business leaders to tackle urgent global health problems, was introduced today in the United States at the GBCHealth Conference.

17 May 2012

U.S. HIV assistance through PEPFAR prevented 740,000 deaths between 2004-2008, study shows

"The lives of more than 740,000 people in nine African countries were saved between 2004 and 2008 by the U.S. President's Emergency Plan for AIDS Relief [PEPFAR]," according to a study conducted by Stanford University School of Medicine researchers and published in the Journal of the American Medical Association (JAMA) on Wednesday, HealthDay News reports.

17 May 2012

TRCARC, IBM partner to strengthen HIV prevention effort

IBM is collaborating with the Thai Red Cross AIDS Research Center (TRCARC) to strengthen HIV prevention effort and to make Bangkok the world's first city to achieve "Zero New HIV Infections" by 2015.

17 May 2012

Reformulated anti-HIV gel may be safe for use in both vagina, rectum

A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In laboratory tests of rectal tissue, researchers from the Microbicide Trials Network (MTN) found that the reformulated gel was less harmful to the lining of the rectum than the original vaginal formulation, and just as effective in protecting cells against HIV.

17 May 2012

New directions and challenges in viral hepatitis care and research

The editors of Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute, are pleased to announce the publication of this year's highly anticipated special 13th issue. Published each May, the 13th issue is devoted to a particular gastroenterological topic of broad interest; this year's topic is viral hepatitis.

16 May 2012

Reuters examines use of statistics in public health ahead of WHO report

"Above all else, analyzing the state of the world's health -- be it by looking at obesity rates, cancer cases, malaria deaths, or HIV-free births -- requires decent statistics," Reuters reports in an article examining the use of statistics in public health ahead of the release of the WHO's World Health Statistics report.

16 May 2012

Newspapers examine concerns surrounding possible FDA approval of Truvada for PrEP

The New York Times and the Financial Times examine concerns expressed by AIDS activists and members of an FDA panel that last week recommended Gilead Sciences' antiretroviral drug Truvada be approved for pre-exposure prophylaxis (PrEP) to prevent HIV among healthy people at risk of contracting the virus.

16 May 2012